 |
 | Home | Contact Us | FAQ | Search & Site Map | Link to Us |
 | Sign In | Join | Other 45 Sites in Network |
Medical Forum / General / General / October 2005Dr. Misbin and Symlin
Dr. Misbin was removed as a FDA reviewer for the drug Symlin (diabetic) and all future reviews of drugs produced by Amylin Corporation. This is per the WSJ for 10/26/05. This is very disturbing. Either Dr. Misbin is anti-Amylin or the FDA has been overly influenced by Amylin. This is an excellent article that raises a lot of questions. For example, why is there no central reporting for drug side-effects that doctors can report to? For example, why is there no central reporting for drug side-effects that doctors can report to? There IS: The FDA has a standard protocol, for both pt.s and prescribers. |
Reply to this Message |
 Sign In
 Join
 My Latest Posts My Monitored Threads My Blog My Photo Gallery My Profile My Homepage Start New Thread Enable EMail Alerts Rate this Thread
|
©2008 Advenet LLC Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.